Table 1.
Gene | Lead SNP | CAD risk allele | Frequency risk allele | OR risk allele | P-value | P-value combined analysis | Relationship of coxib to gene/gene product* | Regulatory effect (Histone marks) |
---|---|---|---|---|---|---|---|---|
BCAR1 | rs4888383 | T | 0.57 | 1.05 | 7.99*10−08 | 2.98*10−08 | inhibition | Promoter/Enhancer |
MMP9 | rs7270354 | A | 0.15 | 1.06 | 6.75*10−08 | 3.34*10−08 | decreased expression | Promoter/Enhancer |
VEGFA | rs6905288 | A | 0.60 | 1.04 | 7.44*10−07 | 8.86*10−07 | decreased expression | Enhancer |
CACNA1E | rs556321 | C | 0.16 | 1.05 | 8.26*10−06 | 8.85*10−06 | inhibition | Promoter/Enhancer |
For each gene, the lead SNP is shown. The regulatory effects were annotated using Haploreg25.